Investment personality
Jim Cramer has endorsed
Mckesson Corporation MCK as a good purchasing option, and other investors seem to agree with this view. For instance,
Wealth Enhancement Advisory Services LLC acquired a significant amount of MCK shares recently. Additionally, MCK's
quarterly earnings are anticipated to garner attention, and the company's stock has generated positive reactions due to its apparent trending status. MCK's decision to acquire
Core Ventures has fueled speculations of a likely uptrend. Meanwhile, analysts have lauded MCK as an undervalued stock that is worth investing in. A substantial
88% ownership by institutional investors suggests strong backing. However, the company's share price recorded a moderate dip in recent times, and even though the company has shown resilient traits, it has faced some challenges such as a quantitative revenue dip affecting its U.S. pharmaceutical segment. Interestingly, MCK's stock dipped on MCK's announcement of
Rexall and Well.ca business sale to Birch Hill Equity Partners. Notwithstanding the revenue miss, MCK's earnings per share soared, and the company's performance
transcends growth and pricing. The company also raised its
quarterly dividend.
Mckesson Corporation MCK News Analytics from Wed, 07 Feb 2024 08:00:00 GMT to Sat, 26 Oct 2024 12:14:58 GMT -
Rating 7
- Innovation 2
- Information 5
- Rumor -3
